# Ceftaroline Pharmacokinetics in Continuous Renal Replacement Therapy

> **NCT04152694** · PHASE4 · COMPLETED · sponsor: **University of Maryland, Baltimore** · enrollment: 4 (actual)

## Conditions studied

- Infection During Renal Replacement Therapy
- Critically Ill

## Interventions

- **OTHER:** Ceftaroline levels in CRRT

## Key facts

- **NCT ID:** NCT04152694
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-09
- **Primary completion:** 2020-09-01
- **Final completion:** 2020-09-01
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2021-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04152694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04152694, "Ceftaroline Pharmacokinetics in Continuous Renal Replacement Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04152694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*